◼ Archived
Health
HIV prevention drug hailed as breakthrough, but who gets access?
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 trends tracked about this subject — the full history, oldest to newest below.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Long-acting lenacapavir shows effective HIV PrEP results after a year, raising urgent questions about patient access.
Analysis of South Africa's first Lenacapavir roll-out data emerges alongside global coverage of the twice-yearly HIV prevention shot.